The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 02, 2013

Filed:

Jun. 14, 2012
Applicants:

Fumihito Sugihara, Osaka, JP;

Naoki Inoue, Osaka, JP;

Seiko Koizumi, Osaka, JP;

Chinfang Liu, Tochigi, JP;

Hajime Takasaki, Osaka, JP;

Hisayuki Kobayashi, Osaka, JP;

Hiroshi Mano, Saitama, JP;

Sachie Nakatani, Saitama, JP;

Masahiro Wada, Saitama, JP;

Inventors:

Fumihito Sugihara, Osaka, JP;

Naoki Inoue, Osaka, JP;

Seiko Koizumi, Osaka, JP;

Chinfang Liu, Tochigi, JP;

Hajime Takasaki, Osaka, JP;

Hisayuki Kobayashi, Osaka, JP;

Hiroshi Mano, Saitama, JP;

Sachie Nakatani, Saitama, JP;

Masahiro Wada, Saitama, JP;

Assignee:

Nitta Gelatin Inc., Osaka, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/05 (2006.01);
U.S. Cl.
CPC ...
Abstract

A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.


Find Patent Forward Citations

Loading…